Table 10.
hsa-miR-16 | hsa-miR122-5p | hsa-miR-198 | hsa-miR199a-3p | hsa-miR221 | hsa-miR23b-3p | hsa-miR34a | ||
HbA1c, % | r2 | 0.312 | 0.027 | 0.017 | 0.087 | 0.156 | 0.384 | 0.498 |
P | < 0.001a | 0.758 | 0.369 | 0.08 | 0.003a | < 0.001a | < 0.001a | |
GLU in mg/dL | r2 | 0.269 | 0.353 | 0.099 | 0.17 | 0.109 | 0.409 | 0.087 |
P | 0.001a | < 0.001a | 0.026 | 0.003a | 0.016 | < 0.001a | 0.08 | |
Insulin in mU/L | r2 | 0.091 | 0.412 | 0.041 | 0.47 | 0.031 | 0.497 | 0.063 |
P | 0.003a | < 0.001a | 0.209 | < 0.001a | 0.003a | < 0.00a | 0.003a | |
HOMA-IR | r2 | 0.096 | 0.419 | 0.013 | 0.098 | 0.49 | 0.492 | 0.027 |
P | 0.03 | < 0.001a | 0.396 | 0.001a | < 0.001a | < 0.001a | 0.001a | |
ISI | r2 | 0.095 | 0.421 | 0.102 | 0.019 | 0.499 | 0.545 | 0.0693 |
P | 0.0074a | < 0.001a | 0.023 | 0.004a | < 0.001a | < 0.001a | 0.005a | |
HIRI | r2 | 0.498 | 0.429 | 0.024 | 0.1807 | 0.427 | 0.672 | 0.049 |
P | < 0.001a | < 0.001a | 0.005 | < 0.001a | < 0.001a | < 0.001a | 0.009a |
Relationship was evaluated through a linear regression analysis adjusted by body mass index, sex, age, high-density lipoproteins, and triglycerides, using SPSS software.
P < 0.05. GLU: Glucose; HbA1c: Glycosylated hemoglobin; HIRI: Hepatic insulin resistance index; HOMA-IR: Homeostasis model assessment-insulin resistance; ISI: Insulin sensitivity index; T2DM: Type 2 diabetes mellitus.